HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Li Guo Selected Research

26S proteasome non-ATPase regulatory subunit 13

1/2014Investigations into the role of 26S proteasome non-ATPase regulatory subunit 13 in neuroinflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Li Guo Research Topics

Disease

100Neoplasms (Cancer)
06/2022 - 01/2011
30Inflammation (Inflammations)
04/2022 - 01/2003
24Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2022 - 09/2012
23Breast Neoplasms (Breast Cancer)
06/2022 - 01/2011
17Infections
06/2022 - 07/2007
17Glaucoma
01/2020 - 01/2005
15Wounds and Injuries (Trauma)
01/2021 - 07/2003
14Alzheimer Disease (Alzheimer's Disease)
07/2022 - 08/2007
13Ischemic Stroke
04/2022 - 05/2012
13Multiple Sclerosis
01/2022 - 09/2012
12Neoplasm Metastasis (Metastasis)
06/2022 - 05/2011
12Leukemia
01/2020 - 01/2006
11Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
06/2021 - 12/2010
11Body Weight (Weight, Body)
01/2021 - 08/2004
10Stroke (Strokes)
04/2022 - 10/2016
10COVID-19
02/2022 - 01/2020
9Hypertension (High Blood Pressure)
02/2022 - 04/2014
8Hepatocellular Carcinoma (Hepatoma)
02/2022 - 01/2018
8Autoimmune Diseases (Autoimmune Disease)
01/2021 - 01/2007
7Carcinogenesis
01/2022 - 03/2013
7Hypoxia (Hypoxemia)
09/2021 - 01/2013
7Carcinoma (Carcinomatosis)
04/2021 - 12/2006
7Obesity
09/2020 - 11/2006
7Ocular Hypertension (Glaucoma, Suspect)
01/2020 - 02/2006
7Reperfusion Injury
11/2018 - 05/2012
6Juvenile Arthritis (Juvenile Idiopathic Arthritis)
10/2022 - 08/2014
6Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2021 - 07/2012
5Neuroinflammatory Diseases
06/2022 - 01/2014
5Rheumatoid Arthritis
01/2022 - 04/2015
5Necrosis
01/2022 - 02/2011
5Demyelinating Diseases (Demyelinating Disease)
01/2022 - 03/2015
5Ischemia
09/2021 - 01/2014
5Hemorrhage
06/2021 - 09/2012
5Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 03/2015
5Virus Diseases (Viral Diseases)
01/2021 - 01/2017
5Sepsis (Septicemia)
01/2021 - 01/2019
5Parkinson Disease (Parkinson's Disease)
10/2020 - 01/2016
5Thrombosis (Thrombus)
10/2020 - 04/2018
5Cataract (Cataracts)
06/2018 - 11/2003
4Communicable Diseases (Infectious Diseases)
05/2022 - 01/2018
4Glioma (Gliomas)
02/2022 - 02/2019
4Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 10/2014
4Diabetes Mellitus
01/2022 - 05/2006
4Fibrosis (Cirrhosis)
01/2022 - 09/2015

Drug/Important Bio-Agent (IBA)

45Proteins (Proteins, Gene)FDA Link
02/2022 - 03/2004
35Biomarkers (Surrogate Marker)IBA
06/2022 - 12/2010
35MicroRNAs (MicroRNA)IBA
06/2022 - 01/2011
23Pharmaceutical PreparationsIBA
01/2021 - 01/2008
16Biological ProductsIBA
06/2022 - 09/2007
16Messenger RNA (mRNA)IBA
01/2022 - 12/2011
16Retinaldehyde (Retinal)IBA
01/2022 - 01/2008
14Glucose (Dextrose)FDA LinkGeneric
09/2021 - 04/2014
12Liposomes (Liposome)IBA
06/2022 - 01/2018
11Neuroprotective AgentsIBA
07/2022 - 02/2006
11RNA (Ribonucleic Acid)IBA
06/2022 - 03/2005
10Peptides (Polypeptides)IBA
01/2022 - 10/2008
10Long Noncoding RNAIBA
01/2022 - 01/2014
9CytokinesIBA
06/2022 - 12/2014
9Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 01/2007
9Therapeutic UsesIBA
01/2022 - 04/2010
9EnzymesIBA
11/2021 - 11/2013
9AntigensIBA
01/2021 - 10/2006
8LigandsIBA
06/2022 - 09/2012
8Interleukin-6 (Interleukin 6)IBA
01/2022 - 02/2011
8Immunoglobulin G (IgG)IBA
01/2022 - 10/2006
8Inosine Triphosphate (ITP)IBA
06/2021 - 12/2010
8LipidsIBA
01/2020 - 01/2015
8AntioxidantsIBA
01/2020 - 11/2013
7CholesterolIBA
07/2022 - 01/2018
6LipopolysaccharidesIBA
07/2021 - 01/2003
6Monoclonal AntibodiesIBA
01/2017 - 01/2006
5Competitive Endogenous RNAIBA
06/2022 - 01/2020
5CurcuminIBA
06/2022 - 01/2018
5Polysaccharides (Glycans)IBA
05/2022 - 09/2012
5Hemoglobins (Hemoglobin)IBA
01/2022 - 04/2014
5CateninsIBA
12/2021 - 10/2014
5NAD (NADH)IBA
09/2021 - 10/2016
5Interleukin-10 (Interleukin 10)IBA
08/2021 - 02/2017
5Indicators and Reagents (Reagents)IBA
06/2021 - 05/2013
5Cisplatin (Platino)FDA LinkGeneric
01/2021 - 09/2012
5Antiviral Agents (Antivirals)IBA
12/2020 - 10/2011
5CollagenIBA
10/2020 - 05/2006
5ResveratrolIBA
09/2020 - 04/2016
5DNA (Deoxyribonucleic Acid)IBA
01/2020 - 09/2002
5Sirolimus (Rapamycin)FDA Link
01/2019 - 09/2012
5PhosphatidylserinesIBA
06/2018 - 11/2016
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2014 - 05/2012
4tocilizumab (atlizumab)FDA Link
10/2022 - 01/2017
4ChemokinesIBA
06/2022 - 05/2011
4Biotin (Vitamin H)FDA Link
06/2022 - 01/2019
4Doxorubicin (Adriamycin)FDA LinkGeneric
02/2022 - 03/2015
4AntibodiesIBA
01/2022 - 09/2012
4Blood Glucose (Blood Sugar)IBA
01/2022 - 01/2016

Therapy/Procedure

49Therapeutics
10/2022 - 07/2005
20Drug Therapy (Chemotherapy)
06/2022 - 07/2006
8Intraperitoneal Injections
08/2021 - 10/2005
7Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 02/2007
5Aftercare (After-Treatment)
03/2022 - 10/2014
5Immunotherapy
01/2022 - 08/2017
5Transplantation
04/2021 - 12/2012